1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preliminary results from a single-arm, phase II study assessing the efficacy of pembrolizumab plus radiotherapy in metastatic triple negative breast cancer
    Meeting Abstract

    Ho, A.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Phung, A.; Wilgucki, M.; Henrich, M.; Arnold, B.; Patil, S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics of endometrial carcinoma metastatic to the ovary compared to endometrial carcinoma with synchronous ovarian carcinoma
    Meeting Abstract

    Rodriguez Gomez Hidalgo, N.; Soslow, R. A.; Weigelt, B.; Sioulas, V.; Aloisi, A.; Abu-Rustum, N.; Mueller, J. J.; Makker, V.; Leitao, M. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I study of mFOLFOX6 and ADI-PEG-20 in patients (pts) with advanced hepatocellular carcinoma (HCC) and other gastrointestinal (GI) malignancies
    Meeting Abstract

    Harding, J. J.; Lowery, M. A.; Uhlitskykh, K.; Wan, P. J.; Hamilton, C. R.; Barba, A.; Liu, K. C. W.; Johnston, A.; Bomalaski, J. S.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • HSD3B1 genotype and response to androgen deprivation therapy for biochemical recurrence after radiotherapy for localized prostate cancer
    Meeting Abstract

    Hearn, J. W. D.; Xie, W.; Nakabayashi, M.; Almassi, N.; Reichard, C. A.; Pomerantz, M.; Kantoff, P. W.; Sharifi, N.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • RASA1 and NF1 co-mutated non-small cell lung carcinomas: Cancer genomic data and evaluation of sensitivity to MEK inhibition
    Meeting Abstract

    Hayashi, T.; Desmeules, P.; Smith, R.; Drilon, A. E.; Somwar, R.; Ladanyi, M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Primary outcomes analysis of a multicenter randomized controlled trial of an interactive decision tool for patients with breast cancer
    Meeting Abstract

    Hawley, S. T.; An, L. C.; Li, Y.; Resnicow, K.; Morrow, M.; Jagsi, R.; Katz, S. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1b study with PEGylated human IL-10 (AM0010) with 5-FU and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Hecht, J. R.; Naing, A.; Falchook, G.; Patel, M. R.; Infante, J. R.; Aljumaily, R.; Wong, D. J. L.; Autio, K. A.; Wainberg, Z. A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma
    Meeting Abstract

    Grommes, C.; Stone, J.; Nolan, C.; Tsyvkin, E.; Wolfe, J.; Mellinghoff, I. K.; DeAngelis, L. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Timing of initiation of defibrotide (DF) post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final data from an expanded-access protocol
    Meeting Abstract

    Grupp, S. A.; Richardson, P. G.; Smith, A. R.; Triplett, B.; Kernan, N. A.; Antin, J. H.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A first in human phase I study of AZD8186, a potent and selective inhibitor of PI3K in patients with advanced solid tumours as monotherapy and in combination with the dual mTORC1/2 inhibitor vistusertib (AZD2014) or abiraterone acetate
    Meeting Abstract

    Hansen, A. R.; Shapiro, G.; Do, K. T.; Kumar, R.; Martin-Liberal, J.; Higano, C. S.; Wisinski, K. B.; Dean, E. J.; Heath, E. I.; Rathkopf, D. E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save